I'm not sure when the videos will become available but I'd also highlight Dr Anna Aschenbrenner's talk that came at the end of day 1. Data from paper in preparation.
Using high-dimensional flow cytometry, they showed changes in NKs. However, they could not find a difference in immune cell subtypes when looking at subgroups based on causative infection (SARS2, EBV, influenza etc). And defined two severity subsets based on transcriptome.
Do you remember what the NK-changes exactly are?
- from the 4th slide, I can see that there are NK cell alterations - higher levels for CD-56
- with Long Covid and infection onset ME CFS patients (vs healthy controls)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.